*Investigational product candidates. The safety and efficacy of RECORLEV (levoketoconazole) and veldoreotide have not been established.
Please see KEVEYIS Important Safety Information and Full Prescribing Information.
For accessibility-related questions, comments, or concerns about this digital property, please email [email protected] and we will reply to your message.
© 2021 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MLR-0010 V20 10/2020
Phone: +1 610-254-9200
[email protected]